首页> 外文期刊>Oncology letters >Circulating tumor cell detection: A direct comparison between negative and unbiased enrichment in lung cancer
【24h】

Circulating tumor cell detection: A direct comparison between negative and unbiased enrichment in lung cancer

机译:循环肿瘤细胞检测:肺癌中负性和无偏富集之间的直接比较

获取原文
获取原文并翻译 | 示例
           

摘要

Circulating tumor cells (CTCs), isolated as a 'liquid biopsy', may provide important diagnostic and prognostic information. Therefore, rapid, reliable and unbiased detection of CTCs are required for routine clinical analyses. It was demonstrated that negative enrichment, an epithelial marker-independent technique for isolating CTCs, exhibits a better efficiency in the detection of CTCs compared with positive enrichment techniques that only use specific anti-epithelial cell adhesion molecules. However, negative enrichment techniques incur significant cell loss during the isolation procedure, and as it is a method that uses only one type of antibody, it is inherently biased. The detection procedure and identification of cell types also relies on skilled and experienced technicians. In the present study, the detection sensitivity of using negative enrichment and a previously described unbiased detection method was compared. The results revealed that unbiased detection methods may efficiently detect > 90% of cancer cells in blood samples containing CTCs. By contrast, only 40-60% of CTCs were detected by negative enrichment. Additionally, CTCs were identified in > 65% of patients with stage I/II lung cancer. This simple yet efficient approach may achieve a high level of sensitivity. It demonstrates a potential for the large-scale clinical implementation of CTC-based diagnostic and prognostic strategies.
机译:循环肿瘤细胞(CTC)分离为“液检”,可以提供重要的诊断和预后信息。因此,常规临床分析需要快速,可靠和无偏异的CTC检测。据证明,对于分离CTCs的离子标记物无关技术,对CTC的检测具有更好的效率,与阳性富集技术相比,仅使用特异性的抗上皮细胞粘附分子。然而,阴性富集技术在隔离过程中产生显着的细胞损失,并且由于它是仅使用一种类型的抗体的方法,因此固有偏置。细胞类型的检测程序和鉴定也依赖于技术人员和经验丰富的技术人员。在本研究中,比较了使用负富集的检测灵敏度和先前描述的未偏叠检测方法。结果表明,无偏见的检测方法可以有效地检测含有CTC的血液样品中的> 90%的癌细胞。相比之下,通过负富集仅检测40-60%的CTC。此外,CTC在> 65%的患者中鉴定了I / II肺癌的65%。这种简单但有效的方法可能达到高水平的灵敏度。它展示了基于CTC的诊断和预后策略的大规模临床实施的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号